Skip to main content
RecallFDAfda-F-2095-2019UNDECLARED ALLERGEN

Lipton DIET ICED TEA PEACH 6/16.9 oz plastic bottles MANUFACTURED BY INDEPENDENT PRODUCERS FOR THE PEPSI/LIPTON TEA PARTNERSHIP, PURCHASE...

Category
Units Affected
42
Recall Date
August 2, 2019
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2095-2019.

The firm stated that they placed Peach Tea Labels on Diet Peach Tea bottles. The product contains undeclared Malic Acid and Citrus Pectin.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2095-2019.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Pepsi Bottling Ventures, Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2095-2019.

Pepsi Bottling Ventures, LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Pepsi Bottling Ventures, Llc Recall FAQ

Pepsi Bottling Ventures, Llc is the subject of a beverages safety report: Lipton DIET ICED TEA PEACH 6/16.9 oz plastic bottles MANUFACTURED BY INDEPENDENT PRODUCERS FOR THE PEPSI/LIPTON TEA PARTNERSHIP, PURCHASE.... The notice was published on August 2, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 42 units are potentially affected.